BZD and Z-Drug FDA labels
Here are links to the FDA-approved labels for the various benzodiazepines and Z-drugs:
Ativan [package insert]. Bridgewater, NJ: Valeant Pharmaceuticals International; September 2016. Label
Ambien [package insert]. Bridgewater, NJ: Sanofi-Aventis US LLC; March, 2017. Label
Dalmane [package insert]. Aliso Viejo, CA: Valeant Pharmaceuticals North America; April 2007. Label
Halcion [package insert]. New York, NY: Pfizer Inc; March 2015. Label
Klonopin [package insert]. South San Francisco, CA: Genetech USA, Inc.; October 2013. Label
Librium [package insert]. Costa Mesa, CA: Valeant Pharmaceuticals International; July 2005. Label
Lunesta [package insert]. Marlborough, MA: Sunovion Pharmaceuticals Inc.; May 2014. Label
Onfi [package insert]. Deerfield, IL, U.S.A: Lundbeck. Label
Restoril [package insert]. Hazelwood, MO: Mallinckrodt Inc.; November 2014. Label
Serax [package insert]. Philadelphia, PA: Wyeth Laboratories, Inc.; June 2000. Label
Sonata [package insert]. New York, NY: Pfizer Inc; May 2013. Label
Tranxene [package insert]. Deerfield, IL: Lundbeck, Inc.; April 2009. Label
Valium [package insert]. South San Francisco, CA: Genetech USA, Inc.; August 2015. Label
Xanax [package insert]. New York, NY: Pfizer Inc; September 2013. Label
Links to other resources embedded in this site
Original research articles on benzodiazepines and Z-drugs can be found at the Benzodiazepine Reference Library.
The most authoritative document on benzodiazepine withdrawal, “Benzodiazepines: How They Work and How to Withdraw” by Dr Heather Ashton, MD, also known as the Ashton Manual, can be found HERE.
Patient-focused websites, such as benzodiazepine withdrawal syndrome support groups can be found HERE.
Medical books on the problems with benzodiazepines can be found HERE.
